Ghent University Academic Bibliography

Your filters: cql: author="Vandenbroucke, Klaas" or (type any "bookEditor issueEditor" and editor="Vandenbroucke, Kl...

Add to list
- Journal Article
- A1
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke, H de Haard, E Beirnaert, T Dreier, M Lauwereys, Lynn Huyck (UGent) , Jacques Van Huysse (UGent) , P Demetter, L Steidler, Erik Remaut (UGent) , et al.

(2010) MUCOSAL IMMUNOLOGY. 3(1). p.49-56
Add to list
Expression of galectins-1,-3 and-4 varies with strain and type of experimental colitis in mice

Anne Mathieu, Nathalie Nagy, Christine Decaestecker, Liesbeth Ferdinande (UGent) , Klaas Vandenbroucke, Pieter Rottiers, Claude Cuvelier (UGent) , Isabelle Salmon and Pieter Demetter

(2008) INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 89(6). p.438-446
Add to list
- Conference Paper
- C3
Intestinal secretion of murine trefoil factor 3 via orally administered L-Lactis shows strong therapeutic effect in 5-fluorouracil induced mucositis

Karolien Van Huynegem, Klaas Vandenbroucke (UGent) , B COULIE and Pieter Rottiers

(2007) GASTROENTEROLOGY. 132(4).
Add to list
Genetically modified Lactococcus lactis: novel tools for drug delivery

Lothar Steidler (UGent) and Klaas Vandenbroucke

(2006) INTERNATIONAL JOURNAL OF DAIRY TECHNOLOGY. 59(2). p.140-146
Add to list
- Conference Paper
- C3
Therapeutic effect of mouse trefoil factor 3 in 5-fluorouracil induced mucositis

K VAN HUYNEGEM, Klaas Vandenbroucke and Pieter Rottiers

(2006) FASEB JOURNAL. 20(5).
Add to list
Clinical potential of Lactococcus lactis mediated delivery of human Interleukin-10 and Trefoil Factors

Erik Remaut (UGent) , H BRAAT, Klaas Vandenbroucke, Pieter Rottiers and Lothar Steidler (UGent)

(2006) Bioscience and microflora. 25(3). p.81-97
Add to list
- Journal Article
- A1
- open access
Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance

Sofie Termont, Klaas Vandenbroucke, Dirk Iserentant (UGent) , Sabine Neirynck, Lothar Steidler (UGent) , Erik Remaut (UGent) and Pieter Rottiers

(2006) APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 72(12). p.7694-7700
Add to list
- PhD Thesis
Genetically modified lactococcus lactis as in vivo delivery system for trefoil factors at the intestinal mucosa / Klaas Vandenbroucke.

Klaas Vandenbroucke

(2004)
Add to list
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice

Klaas Vandenbroucke, Wolfgang Hans, Jacques Van Huysse, Sabine Neirynck, Pieter Demetter, Erik Remaut (UGent) , Pieter Rottiers and Lothar Steidler (UGent)

(2004) GASTROENTEROLOGY. 127(2). p.502-513

Academic Bibliography

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Expression of galectins-1,-3 and-4 varies with strain and type of experimental colitis in mice

Intestinal secretion of murine trefoil factor 3 via orally administered L-Lactis shows strong therapeutic effect in 5-fluorouracil induced mucositis

Genetically modified Lactococcus lactis: novel tools for drug delivery

Therapeutic effect of mouse trefoil factor 3 in 5-fluorouracil induced mucositis

Clinical potential of Lactococcus lactis mediated delivery of human Interleukin-10 and Trefoil Factors

Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance

Genetically modified lactococcus lactis as in vivo delivery system for trefoil factors at the intestinal mucosa / Klaas Vandenbroucke.

Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice

Contents

Support

Contact